Cureus reviewing paper alleged to plagiarize Lancet article

A 2022 paper in Cureus on causes of cancer around the world is under investigation by the journal following inquiries by Retraction Watch prompted by a reader’s email. The paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors,” shares a title and figures with a 2005 paper … Continue reading Cureus reviewing paper alleged to plagiarize Lancet article

‘We should have followed up’: Lancet journal retracts article on hearing aids and dementia after prodding

When Jure Mur, a postdoc at the University of Edinburgh in Scotland, realized the replication of a published study he was working on as a “sanity check” wasn’t producing matching results, his first reaction was “annoyance,” he said.  He assumed the mistake was his own, and he’d have to thoroughly check his work to find … Continue reading ‘We should have followed up’: Lancet journal retracts article on hearing aids and dementia after prodding

Lancet retracts two more papers by convicted surgeon Paolo Macchiarini

The Lancet today retracted two papers by former Karolinska Institutet surgeon Paolo Macchiarini, whose professional and personal escapades have made headlines for more than a decade and who has been sentenced to 30 months in prison for causing bodily harm to his patients. The move comes a month after Sweden’s National Board for Assessment of … Continue reading Lancet retracts two more papers by convicted surgeon Paolo Macchiarini

Highly cited Lancet long COVID study retracted and republished

One of the first studies of long COVID has been retracted and replaced seven months after editors marked it with an expression of concern citing “data errors.”  The original paper, “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study,” was published in The Lancet in January 2021. It was “the first large … Continue reading Highly cited Lancet long COVID study retracted and republished

Five years on, convicted transplant surgeon earns expressions of concern from Lancet

In 2018, when The Lancet pulled two studies by once-celebrated transplant surgeon Paolo Macchiarini after he was found guilty of misconduct, we suggested in a post that the journal’s chapter of the long-running Macchiarini saga was finally over.  We were wrong. Last week, the journal issued expressions of concern about a pair of papers by … Continue reading Five years on, convicted transplant surgeon earns expressions of concern from Lancet

Buzzy Lancet long COVID paper under investigation for ‘data errors’

An early and influential paper on long COVID that appeared in The Lancet has been flagged with an expression of concern while the journal investigates “data errors” brought to light by a reader.  An editorial that accompanied the paper when it was published in January of last year described it as “the first large cohort … Continue reading Buzzy Lancet long COVID paper under investigation for ‘data errors’

The Lancet more than doubles its impact factor, eclipsing NEJM for the first time ever

The Lancet has overtaken the New England Journal of Medicine as the medical journal with the highest impact factor, according to Clarivate’s 2022 update to its Journal Citation Reports. And the jump wasn’t subtle: The Lancet’s impact factor – a controversial measure of how often a journal’s papers are cited on average – more than … Continue reading The Lancet more than doubles its impact factor, eclipsing NEJM for the first time ever

Lancet journal retracts, replaces paper on treatment for pancreatic cancer

A Lancet journal has retracted and replaced a 2021 paper on the treatment of pancreatic cancer over an error that prompted an institutional investigation. The article, “Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial,” appeared … Continue reading Lancet journal retracts, replaces paper on treatment for pancreatic cancer

KCL investigation finds misconduct in Lancet Neurology paper

A Lancet journal has issued an expression of concern for a 2019 paper by a group in the United Kingdom whose work was found to have included fabricated data and other misconduct.   The article, “Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study,” came from a … Continue reading KCL investigation finds misconduct in Lancet Neurology paper

Lancet retracts 10-year-old case report

The Lancet has retracted a decade-old case report by a group from Japan after concluding that the authors misrepresented the originality of the work.  The paper was a case report, titled “Hidden Harm,” by a team at Nihon University School of Medicine in Tokyo. The authors described a 46-year-old woman with a history of self-harming … Continue reading Lancet retracts 10-year-old case report